The aim of this review is to provide a comprehensive bank of knowledge on the topic of ER+/HER2- node-positive BC, including diagnosing nodal involvement, its effect on prognosis, evaluating treatment options and using gene signatures to predict treatment response to systemic therapies. The gene discussed is ERBB2; the disease is breast cancer.